Mode
Text Size
Log in / Sign up
N/A N=76 Randomized Triple-blind Supportive Care

Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?

Osteoarthritis · Post-traumatic; Arthrosis

Enrolled (actual)
76
Serious AEs
1.3%
Results posted
Dec 2013
Primary outcome: Primary: Length of Hospital Stay — 3.5; 2.6 days

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
methylprednisolone acetate (Drug); active comparator (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
New Lexington Clinic
Primary completion
Feb 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Length of Hospital Stay
3.5; 2.6
PRIMARY
Knee Range of Motion
112.5; 112.4
PRIMARY
Knee Society Scores
87.1; 83.3
PRIMARY
Amount of Pain Medication Taken Per Day
47.8; 46.0
PRIMARY
Patient Satisfaction
PRIMARY
Complications, Such as Infections, Hospital Readmissions, Manipulations Under Anesthesia, Etc.
0; 3

Summary

Prior to surgery, a pharmacist will randomly assign participating patients to one of two groups. One group will get an injection in the knee during surgery that contains medications to limit pain and an antibiotic. A second group will get an injection in the knee during surgery that contains the same pain medications and antibiotic along with a corticosteroid to control inflammation. Corticosteroids are anti-inflammatory medications, not to be confused with muscle-building anabolic steroids you may have heard about in the news. Each patient will have an equal chance of being in either of the two groups. This study will test the safety and efficacy of methylprednisolone acetate in the treatment of pain and inflammation following total knee replacement.

Eligibility Criteria

Inclusion Criteria

  • Between ages of 18 and 95
  • Has elected to undergo total knee replacement

Exclusion Criteria

  • Allergy to any of the medications used in the protocol
  • History of kidney disease
  • Rheumatoid arthritis
  • Any systemic conditions associated with chronic pain
  • History of deep knee sepsis in the affected extremity
  • Unable to understand the questions used to obtain the Knee Society Score
  • Minors and prisoners will be excluded from the study
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00492973). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search